Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 11 | $37,971,214 |
Sells | 154 | $129,802,666 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
05 Oct 2022 08:55 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 03 Oct 2022 | Sale | 100 | 34.39 | 3,439 | D |
14 Nov 2022 17:26 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 10 Nov 2022 | Sale | 100 | 39.96 | 3,996 | D |
06 Mar 2024 20:14 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 04 Mar 2024 | Sale | 114 | 36.28 | 4,136 | D |
16 Nov 2022 19:15 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 16 Nov 2022 | Sale | 100 | 46.045 | 4,604 | D |
18 Sep 2023 18:48 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 01 Sep 2023 | Sale | 127 | 50.24 | 6,380 | D |
03 Apr 2024 18:55 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 01 Apr 2024 | Sale | 400 | 25.025 | 10,010 | D |
18 Dec 2023 20:29 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 14 Dec 2023 | Sale | 514 | 20.76 | 10,671 | D |
18 Dec 2023 20:39 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 14 Dec 2023 | Sale | 543 | 20.76 | 11,273 | D |
18 Dec 2023 20:49 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 14 Dec 2023 | Sale | 597 | 20.76 | 12,394 | D |
18 Dec 2023 20:40 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 14 Dec 2023 | Sale | 611 | 20.76 | 12,684 | D |
13 Jun 2024 18:04 | AKRO | Akero Therapeutics Inc | LAMY PATRICK | Senior VP, Commercial Strategy | 11 Jun 2024 | Sale | 569 | 22.641 | 12,883 | D |
05 Jan 2023 18:46 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 03 Jan 2023 | Sale | 300 | 54.8067 | 16,442 | D |
15 Mar 2024 16:42 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 13 Mar 2024 | Sale | 619 | 28.33 | 17,536 | D |
13 Dec 2022 20:24 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 12 Dec 2022 | Sale | 402 | 43.77 | 17,596 | D |
05 Jun 2023 18:23 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 01 Jun 2023 | Sale | 400 | 45.897 | 18,359 | D |
15 Mar 2024 16:42 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 13 Mar 2024 | Sale | 651 | 28.33 | 18,443 | D |
15 Mar 2024 16:45 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 13 Mar 2024 | Sale | 723 | 28.33 | 20,483 | D |
15 Mar 2024 16:44 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 13 Mar 2024 | Sale | 724 | 28.33 | 20,511 | D |
02 Nov 2022 21:52 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 01 Nov 2022 | Sale | 500 | 44.02 | 22,010 | D |
04 Oct 2023 20:33 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 02 Oct 2023 | Sale | 490 | 51.1 | 25,039 | D |
02 Nov 2022 21:52 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 01 Nov 2022 | Sale | 600 | 42.15 | 25,290 | D |
30 Aug 2023 19:04 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 28 Aug 2023 | Sale | 500 | 50.67 | 25,335 | D |
23 Jun 2023 20:06 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 23 Jun 2023 | Sale | 500 | 51.4087 | 25,704 | D |
25 Sep 2023 20:30 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 13 Sep 2023 | Sale | 531 | 50.34 | 26,731 | D |
15 Jun 2023 21:35 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 13 Jun 2023 | Sale | 509 | 55.16 | 28,076 | D |
25 Sep 2023 20:28 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 13 Sep 2023 | Sale | 562 | 50.34 | 28,291 | D |
15 Jun 2023 21:35 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 13 Jun 2023 | Sale | 538 | 55.16 | 29,676 | D |
25 Sep 2023 20:31 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 13 Sep 2023 | Sale | 617 | 50.34 | 31,060 | D |
25 Sep 2023 20:31 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 13 Sep 2023 | Sale | 632 | 50.34 | 31,815 | D |
15 Jun 2023 21:29 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 13 Jun 2023 | Sale | 591 | 55.16 | 32,600 | D |
01 Nov 2022 17:38 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 28 Oct 2022 | Sale | 800 | 41.1204 | 32,896 | D |
15 Jun 2023 21:41 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 13 Jun 2023 | Sale | 606 | 55.16 | 33,427 | D |
18 Dec 2023 20:37 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 14 Dec 2023 | Sale | 1,628 | 20.76 | 33,797 | D |
01 Nov 2022 17:38 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 28 Oct 2022 | Sale | 869 | 41.1204 | 35,734 | I |
05 Jan 2023 18:46 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 03 Jan 2023 | Sale | 800 | 53.0878 | 42,470 | D |
29 Dec 2022 17:41 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 28 Dec 2022 | Sale | 999 | 49.7635 | 49,714 | D |
18 Jan 2023 17:30 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 13 Jan 2023 | Sale | 1,048 | 49.1187 | 51,476 | D |
13 Jun 2024 18:06 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 11 Jun 2024 | Sale | 2,380 | 22.641 | 53,886 | D |
15 Mar 2024 16:43 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 13 Mar 2024 | Sale | 1,969 | 28.33 | 55,782 | D |
06 Jul 2023 20:44 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 03 Jul 2023 | Sale | 1,219 | 46.2896 | 56,427 | D |
13 Jun 2024 18:13 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 11 Jun 2024 | Sale | 2,516 | 22.641 | 56,965 | D |
18 Jan 2023 17:30 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 13 Jan 2023 | Sale | 1,105 | 51.987 | 57,446 | D |
13 Jun 2024 18:11 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 11 Jun 2024 | Sale | 2,825 | 22.641 | 63,961 | D |
13 Jun 2024 18:09 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 11 Jun 2024 | Sale | 2,831 | 22.64 | 64,094 | D |
05 Apr 2023 16:55 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 03 Apr 2023 | Sale | 1,708 | 38.8259 | 66,315 | D |
18 Jan 2023 17:30 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 13 Jan 2023 | Sale | 1,313 | 51.1784 | 67,197 | D |
18 Jan 2023 17:30 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 13 Jan 2023 | Sale | 1,534 | 49.8901 | 76,531 | D |
21 Jun 2023 17:46 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 16 Jun 2023 | Sale | 1,413 | 56.2966 | 79,547 | D |
04 Oct 2023 20:41 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 02 Oct 2023 | Sale | 1,700 | 49.7059 | 84,500 | D |
25 Sep 2023 20:36 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 13 Sep 2023 | Sale | 1,682 | 50.34 | 84,672 | D |
30 Dec 2022 16:26 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 28 Dec 2022 | Sale | 1,700 | 50.0038 | 85,006 | D |
15 Jun 2023 21:38 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 13 Jun 2023 | Sale | 1,613 | 55.16 | 88,973 | D |
05 Jun 2024 17:05 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 03 Jun 2024 | Sale | 5,000 | 19.288 | 96,440 | D |
03 Feb 2023 17:25 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 01 Feb 2023 | Sale | 2,000 | 50.142 | 100,284 | D |
02 May 2024 21:07 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 01 May 2024 | Sale | 5,000 | 20.1499 | 100,750 | D |
03 Mar 2023 16:21 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 01 Mar 2023 | Sale | 2,265 | 45.5412 | 103,151 | D |
25 Sep 2023 20:31 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 21 Sep 2023 | Sale | 2,200 | 48.3577 | 106,387 | D |
03 Apr 2024 18:55 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 01 Apr 2024 | Sale | 4,600 | 24.3267 | 111,903 | D |
02 Jul 2024 18:55 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 01 Jul 2024 | Sale | 5,000 | 23.404 | 117,020 | D |
04 Oct 2023 20:41 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 02 Oct 2023 | Sale | 2,662 | 48.5632 | 129,275 | D |
29 Dec 2023 20:30 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 27 Dec 2023 | Sale | 5,414 | 24 | 129,936 | D |
25 Sep 2023 20:31 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 21 Sep 2023 | Sale | 2,800 | 47.8461 | 133,969 | D |
11 Dec 2023 20:59 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 07 Dec 2023 | Sale | 6,700 | 20.0187 | 134,125 | D |
16 Nov 2022 19:15 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 15 Nov 2022 | Sale | 3,138 | 45.0423 | 141,343 | D |
11 Dec 2023 20:59 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 11 Dec 2023 | Sale | 7,405 | 20.0233 | 148,273 | D |
05 Oct 2022 08:55 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 03 Oct 2022 | Sale | 4,550 | 32.8 | 149,240 | D |
05 Jan 2023 18:46 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 03 Jan 2023 | Sale | 3,000 | 52.0319 | 156,096 | D |
03 May 2023 20:28 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 01 May 2023 | Sale | 3,477 | 45.5045 | 158,219 | D |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 27 Oct 2022 | Sale | 3,693 | 43.2321 | 159,656 | D |
05 Jun 2023 18:23 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 01 Jun 2023 | Sale | 3,914 | 44.1752 | 172,902 | D |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 27 Oct 2022 | Sale | 4,013 | 43.2321 | 173,490 | I |
16 Nov 2022 19:15 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 16 Nov 2022 | Sale | 3,847 | 45.4534 | 174,859 | D |
13 Jun 2024 18:01 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 11 Jun 2024 | Sale | 7,894 | 22.641 | 178,728 | D |
05 Oct 2022 08:55 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 03 Oct 2022 | Sale | 5,350 | 33.57 | 179,600 | D |
12 Oct 2022 16:59 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 10 Oct 2022 | Sale | 5,000 | 37.99 | 189,950 | D |
14 Nov 2022 17:26 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 10 Nov 2022 | Sale | 4,900 | 39.41 | 193,109 | D |
05 Jan 2023 18:46 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 03 Jan 2023 | Sale | 3,800 | 50.8194 | 193,114 | D |
13 Dec 2022 20:24 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 12 Dec 2022 | Sale | 4,598 | 43.18 | 198,542 | D |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 25 Oct 2022 | Sale | 4,515 | 44.9163 | 202,797 | D |
05 Jan 2023 18:46 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 03 Jan 2023 | Sale | 3,900 | 54.371 | 212,047 | D |
27 Oct 2022 21:27 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 26 Oct 2022 | Sale | 4,762 | 45.03 | 214,433 | D |
06 Mar 2024 20:14 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 04 Mar 2024 | Sale | 6,770 | 32.2803 | 218,538 | D |
27 Oct 2022 21:50 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 25 Oct 2022 | Sale | 4,906 | 44.9163 | 220,359 | I |
02 Dec 2022 17:48 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 30 Nov 2022 | Sale | 4,779 | 47.6044 | 227,501 | D |
06 Jul 2023 20:44 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 03 Jul 2023 | Sale | 5,051 | 45.3615 | 229,121 | D |
02 Dec 2022 17:48 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 30 Nov 2022 | Sale | 5,179 | 47.6044 | 246,543 | I |
04 Oct 2023 20:41 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 02 Oct 2023 | Sale | 5,300 | 46.8836 | 248,483 | D |
11 Dec 2023 20:59 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 08 Dec 2023 | Sale | 12,873 | 20.0086 | 257,571 | D |
30 Aug 2023 19:04 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 28 Aug 2023 | Sale | 5,245 | 49.9248 | 261,856 | D |
06 Mar 2024 20:14 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 04 Mar 2024 | Sale | 7,995 | 35.4941 | 283,775 | D |
02 Dec 2022 17:48 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 30 Nov 2022 | Sale | 6,322 | 46.4355 | 293,565 | D |
03 Mar 2023 16:21 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 01 Mar 2023 | Sale | 6,700 | 47.1692 | 316,034 | D |
02 Dec 2022 17:48 | AKRO | Akero Therapeutics Inc | HARRISON SETH LORING | Director | 30 Nov 2022 | Sale | 6,851 | 46.4355 | 318,130 | I |
06 Mar 2024 20:14 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 04 Mar 2024 | Sale | 9,614 | 33.8326 | 325,267 | D |
04 Oct 2023 20:41 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 02 Oct 2023 | Sale | 6,470 | 50.5619 | 327,135 | D |
15 Sep 2022 19:57 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 13 Sep 2022 | Sale | 13,580 | 27.87 | 378,475 | D |
02 Nov 2022 21:52 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 01 Nov 2022 | Sale | 8,900 | 43.47 | 386,883 | D |
15 Sep 2022 19:59 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 13 Sep 2022 | Sale | 13,986 | 28.04 | 392,167 | D |
03 Feb 2023 17:25 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President & CEO | 01 Feb 2023 | Sale | 8,155 | 49.6694 | 405,054 | D |
30 Dec 2022 16:26 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 29 Dec 2022 | Sale | 8,023 | 50.5481 | 405,547 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)